SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 9/02/09 Lexicon Pharmaceuticals, Inc./DE 8-K/A:1,9 6/08/09 2:49K |
Document/Exhibit Description Pages Size 1: 8-K/A Amendment to Current Report -- form8-k_a HTML 21K 2: EX-10.1 Material Contract HTML 19K
Delaware
|
76-0474169
|
|
(State
or other jurisdiction of
incorporation
or organization)
|
(Commission
File Number)
|
(I.R.S.
Employer
Identification
Number)
|
□
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
|
□
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))
|
Exhibit No.
|
Description
|
|
10.1
|
—
|
Amendment,
dated June 8, 2009, to Second Amended and Restated Collaboration and
License Agreement, dated November 30, 2005, with Genentech,
Inc.
|
Company Name | |||
Date:
September 2, 2009
|
By:
|
/s/ Jeffrey L. Wade | |
Jeffrey L. Wade | |||
Executive
Vice President and
General
Counsel
|
|||
Exhibit No.
|
Description
|
|
10.1
|
—
|
Amendment,
dated June 8, 2009, to Second Amended and Restated Collaboration and
License Agreement, dated November 30, 2005, with Genentech,
Inc.
|
This ‘8-K/A’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 9/2/09 | 8-K, S-3 | ||
For Period End: | 6/8/09 | 8-K | ||
11/30/05 | 8-K | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/03/23 Lexicon Pharmaceuticals, Inc. 10-K 12/31/22 73:7.6M 3/10/22 Lexicon Pharmaceuticals, Inc. 10-K 12/31/21 82:7.6M 3/12/21 Lexicon Pharmaceuticals, Inc. 10-K 12/31/20 82:7.9M |